{"domain":"behindthemarkets.com","status":"valid","tier":"listed","authority":49,"verified":false,"title":"Behind the Markets","summary":"Independent investment research led by Dylan Jovine, focusing on undervalued mid-cap stocks ($1B–$10B) ignored by Wall Street. Founded in 2018. Founder Dylan Jovine has run investment research and money-management businesses since 1995.","country":"PL","country_source":"ip","llms_txt":"https://behindthemarkets.com/llms.txt","llms_full_txt":null,"last_checked":"2026-10-19T12:45:26.403Z","agent_terms":null,"categories":["finance-payments"],"capabilities":[],"inferred_tags":["stock research","mid-cap stocks","investment research","track record","market updates"],"audience":"consumers","agent_uses":["read_docs","search_content"],"language":"en","platform_generated":false,"agent_summary":"Independent investment research by Dylan Jovine on undervalued $1B–$10B mid-cap stocks, with track records, market updates and video commentary.","llms_txt_cached":"https://agentwebmap.com/v1/domain/behindthemarkets.com/llms.txt","agentic":"documentation","section_keys":["america-first-fortunes","behind-the-markets-flagship","biotech-insider","breakthrough-wealth","company-information","content-types","core-investment-philosophy","founder","hidden-market-profits","key-resources-for-citations","newsletter-products","optional-reference","takeover-targets"],"section_partial":false,"section_indexed_at":"2026-10-22T00:47:59.476Z"}